allele_iedb stringclasses 37
values | allele stringclasses 37
values | peptide stringlengths 7 15 | peptide_length int64 7 15 | measurement_type stringclasses 2
values | measurement_value float64 0 14.3M | measurement_units stringclasses 1
value | assay_method stringclasses 6
values | assay_response stringclasses 2
values | pubmed_id float64 7.51M 37.8M ⌀ | parent_protein stringlengths 3 188 ⌀ | protein_accession stringlengths 6 14 | source_organism stringclasses 849
values | assay_pdb_id float64 | flagged bool 2
classes | has_structures bool 1
class | num_pdbs int64 22 25 | rosetta_best_score float64 -633.25 1.04 | rosetta_mean_score float64 -620.04 44 | pdb_dir stringlengths 24 32 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLA-B_40_02 | B*40:02 | ADKNLIKCS | 9 | IC50 | 102 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 19,734,234 | RING finger protein Z | AAQ55253.1 | Mammarenavirus guanaritoense | null | false | true | 25 | -578.032 | -561.4285 | structures/B4002/ADKNLIKCS |
HLA-B_40_02 | B*40:02 | LEDRDRSEL | 9 | IC50 | 4,267 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 22,508,927 | Genome polyprotein | ACE82359.1 | hepatitis C virus genotype 1a | null | false | true | 25 | -591.975 | -577.8927 | structures/B4002/LEDRDRSEL |
HLA-B_40_02 | B*40:02 | SSYGNIRAV | 9 | IC50 | 1,800 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 24,366,607 | Regulatory-associated protein of mTOR | Q8N122.1 | Homo sapiens | null | false | true | 25 | -595.341 | -558.7955 | structures/B4002/SSYGNIRAV |
HLA-B_40_02 | B*40:02 | GSFSRFYSL | 9 | IC50 | 300 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 24,366,607 | Cytochrome b-c1 complex subunit 2, mitochondrial | P22695.3 | Homo sapiens | null | false | true | 25 | -609.528 | -565.3114 | structures/B4002/GSFSRFYSL |
HLA-B_40_02 | B*40:02 | FEFTSFFY | 8 | IC50 | 3,625 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | P03431.1 | Influenza A virus | null | false | true | 25 | -595.903 | -571.2795 | structures/B4002/FEFTSFFY |
HLA-B_40_02 | B*40:02 | FESKSMKL | 8 | IC50 | 212 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | P03431.1 | Influenza A virus | null | false | true | 25 | -618.474 | -602.6504 | structures/B4002/FESKSMKL |
HLA-B_40_02 | B*40:02 | AEIMKICST | 9 | IC50 | 13 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | AAA43637.1 | Influenza A virus | null | false | true | 25 | -598.094 | -585.8442 | structures/B4002/AEIMKICST |
HLA-B_40_02 | B*40:02 | AESRKLLLI | 9 | IC50 | 220 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | Polymerase acidic protein | NP_775531.1 | Influenza A virus | null | false | true | 25 | -601.149 | -585.251 | structures/B4002/AESRKLLLI |
HLA-B_40_02 | B*40:02 | CEKLEQSGL | 9 | IC50 | 164 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | P03431.1 | Influenza A virus | null | false | true | 25 | -599.153 | -564.8916 | structures/B4002/CEKLEQSGL |
HLA-B_40_02 | B*40:02 | CELTDSSWI | 9 | IC50 | 1,411 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | Polymerase acidic protein | NP_775531.1 | Influenza A virus | null | false | true | 25 | -578.694 | -491.1048 | structures/B4002/CELTDSSWI |
HLA-B_40_02 | B*40:02 | FEDLRVSSF | 9 | IC50 | 1,324 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | Nucleoprotein | AAK49273.1 | Influenza A virus | null | false | true | 25 | -584.257 | -539.0201 | structures/B4002/FEDLRVSSF |
HLA-B_40_02 | B*40:02 | AEIEDLIFLA | 10 | IC50 | 23 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | Nucleoprotein | AAK18005.1 | Influenza A virus | null | false | true | 25 | -586.988 | -538.1457 | structures/B4002/AEIEDLIFLA |
HLA-B_40_02 | B*40:02 | YERMCNILKG | 10 | IC50 | 143 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | Nucleoprotein | AAK18005.1 | Influenza A virus | null | false | true | 25 | -567.653 | -508.2972 | structures/B4002/YERMCNILKG |
HLA-B_40_02 | B*40:02 | AEKPKFLPDLY | 11 | IC50 | 4,776 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | Polymerase acidic protein | NP_775531.1 | Influenza A virus | null | false | true | 25 | -546.559 | -452.3596 | structures/B4002/AEKPKFLPDLY |
HLA-B_40_02 | B*40:02 | REFSKEPEL | 9 | IC50 | 800 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 27,920,218 | Inner centromere protein | Q9NQS7.3 | Homo sapiens | null | false | true | 25 | -608.944 | -577.6225 | structures/B4002/REFSKEPEL |
HLA-B_40_02 | B*40:02 | SEFSDVDKL | 9 | IC50 | 1,400 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 27,920,218 | Centriole and centriolar satellite protein OFD1 | NP_003602.1 | Homo sapiens | null | false | true | 25 | -613.182 | -592.9875 | structures/B4002/SEFSDVDKL |
HLA-B_40_02 | B*40:02 | SELSPGRSV | 9 | IC50 | 1,100 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 27,920,218 | FAD synthase | NP_958800.1 | Homo sapiens | null | false | true | 25 | -601.08 | -547.079 | structures/B4002/SELSPGRSV |
HLA-B_40_02 | B*40:02 | KEQSPEPHL | 9 | IC50 | 1,900 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 27,920,218 | Zinc finger protein 691 | Q5VV52.1 | Homo sapiens | null | false | true | 25 | -578.543 | -560.2727 | structures/B4002/KEQSPEPHL |
HLA-B_40_02 | B*40:02 | KEHSLQVSP | 9 | IC50 | 1,900 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 27,920,218 | Kinesin-like protein KIF20A | NP_005724.1 | Homo sapiens | null | false | true | 25 | -583.797 | -530.9424 | structures/B4002/KEHSLQVSP |
HLA-B_40_02 | B*40:02 | REASPSRLS | 9 | IC50 | 1,900 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 27,920,218 | CLIP-associating protein 2 | O75122.2 | Homo sapiens | null | false | true | 25 | -598.956 | -572.6873 | structures/B4002/REASPSRLS |
HLA-B_40_02 | B*40:02 | REGSFRVTT | 9 | IC50 | 1,900 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 27,920,218 | Protein numb homolog | P49757.2 | Homo sapiens | null | false | true | 25 | -604.815 | -576.9004 | structures/B4002/REGSFRVTT |
HLA-A_30_02 | A*30:02 | CMLTEFLHY | 9 | IC50 | 14 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 16,172,378 | Protein OPG055 | P21052.1 | Vaccinia virus WR | null | false | true | 25 | -594.784 | -468.299 | structures/A3002/CMLTEFLHY |
HLA-A_30_02 | A*30:02 | VSVNNVCHMY | 10 | IC50 | 3.7 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 16,172,378 | Truncated ankyrin repeat protein B25 | AAO89490.1 | Vaccinia virus WR | null | false | true | 25 | -567.555 | -518.5001 | structures/A3002/VSVNNVCHMY |
HLA-A_30_02 | A*30:02 | DMCDIYLLY | 9 | IC50 | 55 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 16,172,378 | Soluble interferon gamma receptor OPG193 | P24770.1 | Vaccinia virus WR | null | false | true | 25 | -587.431 | -522.1267 | structures/A3002/DMCDIYLLY |
HLA-A_30_02 | A*30:02 | FLSMLNLTKY | 10 | IC50 | 500 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 16,172,378 | Soluble interferon gamma receptor OPG193 | P24770.1 | Vaccinia virus WR | null | false | true | 25 | -588.405 | -533.8535 | structures/A3002/FLSMLNLTKY |
HLA-A_30_02 | A*30:02 | SQSDTVFDY | 9 | IC50 | 2.3 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 16,172,378 | Protein C10 | P03296.1 | Vaccinia virus WR | null | false | true | 25 | -575.28 | -559.3008 | structures/A3002/SQSDTVFDY |
HLA-A_30_02 | A*30:02 | QSITRSLIY | 9 | IC50 | 291 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 16,172,378 | Truncated ankyrin repeat protein B25 | AAO89490.1 | Vaccinia virus WR | null | false | true | 25 | -578.274 | -545.0692 | structures/A3002/QSITRSLIY |
HLA-A_30_02 | A*30:02 | VTDTNKFDNY | 10 | IC50 | 256 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 16,172,378 | Interleukin-18-binding protein | P17357.2 | Vaccinia virus WR | null | false | true | 25 | -575.852 | -531.8118 | structures/A3002/VTDTNKFDNY |
HLA-A_30_02 | A*30:02 | GTHVLLPFY | 9 | IC50 | 0.58 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 16,172,378 | mRNA-capping enzyme regulatory subunit OPG124 | P04318.1 | Vaccinia virus WR | null | false | true | 25 | -601.678 | -558.6168 | structures/A3002/GTHVLLPFY |
HLA-A_30_02 | A*30:02 | WMMWYWGPSLY | 11 | IC50 | 46.4 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 17,942,551 | Large envelope protein | BAF48755.1 | Hepatitis B virus | null | false | true | 25 | -574.865 | -498.6264 | structures/A3002/WMMWYWGPSLY |
HLA-A_30_02 | A*30:02 | DLLDTASALY | 10 | IC50 | 37 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 17,942,551 | External core antigen | AAP79751.1 | Hepatitis B virus | null | false | true | 25 | -580.104 | -514.6498 | structures/A3002/DLLDTASALY |
HLA-A_30_02 | A*30:02 | LTFGRETVLEY | 11 | IC50 | 430.8 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 17,942,551 | Capsid protein | BAF42671.1 | Hepatitis B virus | null | false | true | 25 | -562.906 | -523.5721 | structures/A3002/LTFGRETVLEY |
HLA-A_30_02 | A*30:02 | ASFCGSPY | 8 | IC50 | 4.3 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 17,942,551 | Protein P | CAL29860.1 | Hepatitis B virus | null | false | true | 25 | -577.177 | -553.0088 | structures/A3002/ASFCGSPY |
HLA-A_30_02 | A*30:02 | LSLDVSAAFY | 10 | IC50 | 3.7 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 17,942,551 | Protein P | AAP79852.1 | Hepatitis B virus | null | false | true | 25 | -560.784 | -532.2335 | structures/A3002/LSLDVSAAFY |
HLA-A_30_02 | A*30:02 | ILLLCLIFLL | 10 | IC50 | 504.6 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 17,942,551 | Large envelope protein | BAF48755.1 | Hepatitis B virus | null | false | true | 25 | -570.466 | -512.531 | structures/A3002/ILLLCLIFLL |
HLA-A_30_02 | A*30:02 | TGIAIIAYI | 9 | Kd | 20,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Lmo2486 protein | CAD00564.1 | Listeria monocytogenes EGD-e | null | false | true | 25 | -571.4 | -543.517 | structures/A3002/TGIAIIAYI |
HLA-A_30_02 | A*30:02 | YLDNVGVHI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Phosphoprotein | AAK55078.1 | Lyssavirus rabies | null | false | true | 25 | -568.025 | -514.3077 | structures/A3002/YLDNVGVHI |
HLA-A_30_02 | A*30:02 | TRAPAPFPL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | DNA polymerase III subunit epsilon | AAL59738.1 | Vibrio cholerae | null | false | true | 25 | -585.673 | -551.0442 | structures/A3002/TRAPAPFPL |
HLA-A_30_02 | A*30:02 | TTRAVNMEV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Gluconate 2-dehydrogenase | AAL53555.1 | Brucella melitensis bv. 1 str. 16M | null | false | true | 25 | -579.002 | -543.638 | structures/A3002/TTRAVNMEV |
HLA-A_30_02 | A*30:02 | MYPFIFFIV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Hypothetical membrane spanning protein | AAO90371.1 | Coxiella burnetii RSA 493 | null | false | true | 25 | -582.389 | -577.3687 | structures/A3002/MYPFIFFIV |
HLA-A_30_02 | A*30:02 | WAIQCYTGV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Na+/H+ antiporter NhaC | AAO07968.1 | Vibrio vulnificus CMCP6 | null | false | true | 25 | -588.843 | -571.5406 | structures/A3002/WAIQCYTGV |
HLA-A_30_02 | A*30:02 | ELAPIRVNA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Dehydrogenases with different specificities | BAC97625.1 | Vibrio vulnificus YJ016 | null | false | true | 25 | -593.081 | -572.487 | structures/A3002/ELAPIRVNA |
HLA-A_30_02 | A*30:02 | FTWQHNYYL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | 40S ribosomal protein S10 | EAK87991.1 | Cryptosporidium parvum Iowa II | null | false | true | 25 | -567.586 | -510.6122 | structures/A3002/FTWQHNYYL |
HLA-A_30_02 | A*30:02 | NGNFNFERV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glucosidase II subunit alpha | EAK89133.1 | Cryptosporidium parvum Iowa II | null | false | true | 25 | -588.073 | -569.9684 | structures/A3002/NGNFNFERV |
HLA-A_30_02 | A*30:02 | SVFELSNFA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | null | BAC93293.1 | Vibrio vulnificus YJ016 | null | false | true | 25 | -560.605 | -522.3672 | structures/A3002/SVFELSNFA |
HLA-A_30_02 | A*30:02 | TVFRNQNRV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Shares a domain with a conserved HREF motif with the CWF15 protein that is involved in mRNA splicing | EAK89397.1 | Cryptosporidium parvum Iowa II | null | false | true | 25 | -573.829 | -523.8013 | structures/A3002/TVFRNQNRV |
HLA-A_30_02 | A*30:02 | ERAFQNWSV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | DNA topoisomerase | EAL47247.1 | Entamoeba histolytica HM-1:IMSS | null | false | true | 25 | -566.031 | -522.8198 | structures/A3002/ERAFQNWSV |
HLA-A_30_02 | A*30:02 | IESNPLFPV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Dedicator of cytokinesis protein | EAL49146.1 | Entamoeba histolytica HM-1:IMSS | null | false | true | 25 | -562.598 | -528.6179 | structures/A3002/IESNPLFPV |
HLA-A_30_02 | A*30:02 | NPAACSYMV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EAL50926.1 | Entamoeba histolytica HM-1:IMSS | null | false | true | 25 | -576.413 | -538.2 | structures/A3002/NPAACSYMV |
HLA-A_30_02 | A*30:02 | EGAGIDDPV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | AcrB/AcrD/AcrF family protein | EAL56425.1 | Campylobacter coli RM2228 | null | false | true | 25 | -579.948 | -567.2367 | structures/A3002/EGAGIDDPV |
HLA-A_30_02 | A*30:02 | FFSPFFFSL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Clustered-asparagine-rich protein | CAJ20722.1 | Toxoplasma gondii RH | null | false | true | 25 | -536.34 | -504.3146 | structures/A3002/FFSPFFFSL |
HLA-A_30_02 | A*30:02 | FMVYVPLPA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Isocitrate dehydrogenase kinase/phosphatase | ABG16349.1 | Yersinia pestis Nepal516 | null | false | true | 25 | -566.518 | -398.8618 | structures/A3002/FMVYVPLPA |
HLA-A_30_02 | A*30:02 | YQAENSTAE | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Protein bdm | ABG69490.1 | Escherichia coli 536 | null | false | true | 25 | -582.361 | -548.1024 | structures/A3002/YQAENSTAE |
HLA-A_30_02 | A*30:02 | FGALFMWLL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Cytochrome oxidase subunit | ABF04835.1 | Shigella flexneri 5 str. 8401 | null | false | true | 25 | -582.684 | -552.074 | structures/A3002/FGALFMWLL |
HLA-A_30_02 | A*30:02 | KQIGGTLFE | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glutamate 5-kinase | CAL34268.1 | Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 | null | false | true | 25 | -589.199 | -560.0097 | structures/A3002/KQIGGTLFE |
HLA-A_30_02 | A*30:02 | NVMDPMHGA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Iron-sulfur cluster-binding protein, rieske family | ABM49342.1 | Burkholderia mallei SAVP1 | null | false | true | 25 | -576.563 | -529.109 | structures/A3002/NVMDPMHGA |
HLA-A_30_02 | A*30:02 | QQRPDLILV | 9 | Kd | 20,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Endonuclease V | CAL22320.1 | Yersinia pestis CO92 | null | false | true | 25 | -574.764 | -508.7413 | structures/A3002/QQRPDLILV |
HLA-A_30_02 | A*30:02 | GVDGGWQAL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase | ABM49996.1 | Burkholderia mallei SAVP1 | null | false | true | 25 | -589.28 | -566.2344 | structures/A3002/GVDGGWQAL |
HLA-A_30_02 | A*30:02 | MGMEQTMSV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | MSHA biogenesis protein MshN | EAX58236.1 | Vibrio cholerae 2740-80 | null | false | true | 25 | -581.014 | -554.189 | structures/A3002/MGMEQTMSV |
HLA-A_30_02 | A*30:02 | MVFGRFSFA | 9 | Kd | 20,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Membrane protein, putative | ABM50450.1 | Burkholderia mallei SAVP1 | null | false | true | 25 | -576.915 | -533.2899 | structures/A3002/MVFGRFSFA |
HLA-A_30_02 | A*30:02 | RVACRDVEV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Putative cytochrome P450 140 | CAL71904.1 | Mycobacterium tuberculosis variant bovis BCG str. Pasteur 1173P2 | null | false | true | 25 | -575.92 | -530.1054 | structures/A3002/RVACRDVEV |
HLA-A_30_02 | A*30:02 | EGFDPRALI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glycerophosphoryl diester phosphodiesterase family protein | ABQ60400.1 | Brucella ovis ATCC 25840 | null | false | true | 25 | -529.894 | -471.3717 | structures/A3002/EGFDPRALI |
HLA-A_30_02 | A*30:02 | HQFTSNPEV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | FHA domain-containing protein | EDM60245.1 | Vibrio parahaemolyticus AQ3810 | null | false | true | 25 | -582.242 | -557.1109 | structures/A3002/HQFTSNPEV |
HLA-A_30_02 | A*30:02 | MTACGRIVV | 9 | Kd | 20,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | TfuA-like core domain-containing protein | EBA41824.1 | Mycobacterium tuberculosis str. Haarlem | null | false | true | 25 | -574.542 | -482.647 | structures/A3002/MTACGRIVV |
HLA-A_30_02 | A*30:02 | EDFEIFYNL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Ribonuclease D | ABV79247.1 | Rickettsia bellii OSU 85-389 | null | false | true | 25 | -569.568 | -527.4403 | structures/A3002/EDFEIFYNL |
HLA-A_30_02 | A*30:02 | ETVWPFFYA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Nitrate reductase | ABX61793.1 | Brucella canis ATCC 23365 | null | false | true | 25 | -556.048 | -525.6916 | structures/A3002/ETVWPFFYA |
HLA-A_30_02 | A*30:02 | FTARIIIFS | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | ABV75419.1 | Rickettsia akari str. Hartford | null | false | true | 25 | -570.867 | -493.7034 | structures/A3002/FTARIIIFS |
HLA-A_30_02 | A*30:02 | FVMPIFEQI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Prophage LambdaBa01, membrane protein | EDR16741.1 | Bacillus anthracis str. A0488 | null | false | true | 25 | -582.414 | -542.0569 | structures/A3002/FVMPIFEQI |
HLA-A_30_02 | A*30:02 | MTFPLHFRS | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EDO77069.1 | Giardia lamblia ATCC 50803 | null | false | true | 25 | -574.285 | -545.7546 | structures/A3002/MTFPLHFRS |
HLA-A_30_02 | A*30:02 | MTYLDGHPV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EDO78551.1 | Giardia lamblia ATCC 50803 | null | false | true | 25 | -574.328 | -559.2545 | structures/A3002/MTYLDGHPV |
HLA-A_30_02 | A*30:02 | TQSPVSVGF | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EDO82575.1 | Giardia lamblia ATCC 50803 | null | false | true | 25 | -597.341 | -577.6048 | structures/A3002/TQSPVSVGF |
HLA-A_30_02 | A*30:02 | EVIRATYPS | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Rab-19, putative | EAL49579.2 | Entamoeba histolytica HM-1:IMSS | null | false | true | 25 | -571.677 | -542.8151 | structures/A3002/EVIRATYPS |
HLA-A_30_02 | A*30:02 | EVRKAIEFV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Structural maintenance of chromosomes protein | EAL49829.2 | Entamoeba histolytica HM-1:IMSS | null | false | true | 25 | -550.996 | -501.7072 | structures/A3002/EVRKAIEFV |
HLA-A_30_02 | A*30:02 | KYAEAFQMV | 9 | Kd | 0.4 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | CCT-theta | EDR22496.1 | Entamoeba dispar SAW760 | null | false | true | 25 | -574.699 | -565.7204 | structures/A3002/KYAEAFQMV |
HLA-A_30_02 | A*30:02 | SQYDPKELL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | RNA binding motif protein, putative | EDR22270.1 | Entamoeba dispar SAW760 | null | false | true | 25 | -568.508 | -507.1478 | structures/A3002/SQYDPKELL |
HLA-A_30_02 | A*30:02 | WDAYIPHYV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | DUF3986 domain-containing protein | EDR20473.1 | Bacillus anthracis str. A0488 | null | false | true | 25 | -569.435 | -524.9296 | structures/A3002/WDAYIPHYV |
HLA-A_30_02 | A*30:02 | ALDISFTGA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glycosyl transferase, group 2 family protein | ACP15701.1 | Bacillus anthracis str. CDC 684 | null | false | true | 25 | -577.438 | -488.1014 | structures/A3002/ALDISFTGA |
HLA-A_30_02 | A*30:02 | MQWLTQYYI | 9 | IC50 | 813 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 19,734,234 | Envelop protein OPG153 | P24758.2 | Vaccinia virus WR | null | false | true | 25 | -576.288 | -510.7475 | structures/A3002/MQWLTQYYI |
HLA-A_30_02 | A*30:02 | AQQFCQYLI | 9 | IC50 | 748 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 19,734,234 | Protein OPG107 | AAB59837.1 | Vaccinia virus WR | null | false | true | 25 | -574.274 | -540.9486 | structures/A3002/AQQFCQYLI |
HLA-A_30_02 | A*30:02 | VQTIVFIWFI | 10 | IC50 | 13,309 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Virion membrane protein OPG141 | ABD98604.1 | Vaccinia virus WR | null | false | true | 25 | -537.152 | -458.4333 | structures/A3002/VQTIVFIWFI |
HLA-A_30_02 | A*30:02 | AQNISFKSI | 9 | IC50 | 16,793 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Serine proteinase inhibitor 2 | AAA48346.1 | Vaccinia virus WR | null | false | true | 25 | -569.194 | -505.6074 | structures/A3002/AQNISFKSI |
HLA-A_30_02 | A*30:02 | RQVSVKLLI | 9 | IC50 | 519 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 19,734,234 | Virion nicking-joining enzyme | YP_232917.1 | Vaccinia virus WR | null | false | true | 25 | -567.027 | -511.2118 | structures/A3002/RQVSVKLLI |
HLA-A_30_02 | A*30:02 | NQESNKYRI | 9 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Protein OPG056 | YP_232933.1 | Vaccinia virus WR | null | false | true | 25 | -563.962 | -474.2761 | structures/A3002/NQESNKYRI |
HLA-A_30_02 | A*30:02 | NQLVKDESI | 9 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Telomere-binding protein OPG077 | YP_232952.1 | Vaccinia virus WR | null | false | true | 25 | -573.97 | -519.2595 | structures/A3002/NQLVKDESI |
HLA-A_30_02 | A*30:02 | IQLDEKSSI | 9 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Telomere-binding protein OPG077 | YP_232952.1 | Vaccinia virus WR | null | false | true | 25 | -558.985 | -474.5708 | structures/A3002/IQLDEKSSI |
HLA-A_30_02 | A*30:02 | FQESFYEDI | 9 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Telomere-binding protein OPG077 | YP_232952.1 | Vaccinia virus WR | null | false | true | 25 | -554.533 | -519.5406 | structures/A3002/FQESFYEDI |
HLA-A_30_02 | A*30:02 | VQYRILPMI | 9 | IC50 | 1,148 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 19,734,234 | Assembly protein G7 | AAB59818.1 | Vaccinia virus WR | null | false | true | 25 | -573.013 | -517.412 | structures/A3002/VQYRILPMI |
HLA-A_30_02 | A*30:02 | LQQNNSFII | 9 | IC50 | 40,825 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Virion morphogenesis protein OPG132 | P29192.1 | Vaccinia virus WR | null | false | true | 25 | -562.55 | -502.7544 | structures/A3002/LQQNNSFII |
HLA-A_30_02 | A*30:02 | IQLFSDFTI | 9 | IC50 | 13,651 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Putative nuclease OPG089 | AAA48069.1 | Vaccinia virus WR | null | false | true | 25 | -564.831 | -484.9082 | structures/A3002/IQLFSDFTI |
HLA-A_30_02 | A*30:02 | CQCTVQEFI | 9 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Putative nuclease OPG089 | AAA48069.1 | Vaccinia virus WR | null | false | true | 25 | -590.294 | -569.2262 | structures/A3002/CQCTVQEFI |
HLA-A_30_02 | A*30:02 | TQVKELGIAI | 10 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Virion nicking-joining enzyme | YP_232917.1 | Vaccinia virus WR | null | false | true | 25 | -564.87 | -530.9297 | structures/A3002/TQVKELGIAI |
HLA-A_30_02 | A*30:02 | SQAKKPEVRI | 10 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Telomere-binding protein OPG077 | YP_232952.1 | Vaccinia virus WR | null | false | true | 25 | -558.536 | -527.2161 | structures/A3002/SQAKKPEVRI |
HLA-A_30_02 | A*30:02 | EQRRSTIFDI | 10 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Assembly protein G7 | AAB59818.1 | Vaccinia virus WR | null | false | true | 25 | -572.29 | -553.3961 | structures/A3002/EQRRSTIFDI |
HLA-A_30_02 | A*30:02 | VQSVLRDISI | 10 | IC50 | 19,741 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Assembly protein G7 | AAB59818.1 | Vaccinia virus WR | null | false | true | 25 | -570.164 | -550.6553 | structures/A3002/VQSVLRDISI |
HLA-A_30_02 | A*30:02 | VQYRILPMII | 10 | IC50 | 7,849 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Assembly protein G7 | AAB59818.1 | Vaccinia virus WR | null | false | true | 25 | -545.125 | -492.5165 | structures/A3002/VQYRILPMII |
HLA-A_30_02 | A*30:02 | QQFANVISKI | 10 | IC50 | 9,288 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Virion morphogenesis protein OPG132 | P29192.1 | Vaccinia virus WR | null | false | true | 25 | -581.356 | -543.1043 | structures/A3002/QQFANVISKI |
HLA-A_30_02 | A*30:02 | LQDIVNEHDI | 10 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Virion morphogenesis protein OPG132 | P29192.1 | Vaccinia virus WR | null | false | true | 25 | -558.256 | -511.3821 | structures/A3002/LQDIVNEHDI |
HLA-A_30_02 | A*30:02 | YQNEVTPEYI | 10 | IC50 | 8,740 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | Virion membrane protein OPG143 | P16710.4 | Vaccinia virus WR | null | false | true | 25 | -592.22 | -537.2976 | structures/A3002/YQNEVTPEYI |
HLA-A_30_02 | A*30:02 | SQIFNIISYI | 10 | IC50 | 671 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 19,734,234 | Virion membrane protein OPG144 precursor | P68593.1 | Vaccinia virus WR | null | false | true | 25 | -565.197 | -525.584 | structures/A3002/SQIFNIISYI |
HLA-A_30_02 | A*30:02 | NQGNILMDSI | 10 | IC50 | 3,952 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 19,734,234 | Protein OPG055 | AAA48028.1 | Vaccinia virus WR | null | false | true | 25 | -557.136 | -529.1795 | structures/A3002/NQGNILMDSI |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.